Sustainability & Climate

After 65 years, Generac is a finalist for Wisconsin's top manufacturing award, lauded for its tech innovation, economic impact, and community investment.

A new stamp-sized oral film could replace the dreaded epinephrine needle. Aquestive's Anaphylm shows promise, but faces regulatory and market hurdles.

A new partnership will supply Japan's surging cell therapy sector with critical, GMP-grade materials, aiming to accelerate the path from lab to clinic.

Global distributor IMCD deepens its food and nutrition footprint with the strategic acquisition of Willows Ingredients, targeting high-growth niche markets.

A landmark agreement sees Tla’amin Nation acquire a massive forest tenure, blending traditional stewardship with a new model for BC's forestry industry.

UDC's 11% dividend hike marks its eighth straight year of increases, reflecting deep confidence in the booming, multi-billion dollar OLED technology market.

A landmark bill to shield living organ donors from job and insurance discrimination is advancing in the Senate, offering new hope for 90,000+ on the waiting list.

With a securitization 5x oversubscribed, Kiavi unlocks $1.2B in new funding, proving investor confidence in its AI-powered real estate lending platform.

MAIA Pharmaceuticals will bring Teribone™, a proven therapy used in Japan, to the US, aiming to solve the critical patient adherence crisis in osteoporosis care.

Chubb promotes veterans Scott Henck and Cynthia Bentley to top actuarial roles, signaling a strategic focus on analytics and continuity amid industry change.

As a gruesome screwworm parasite nears the Texas border, the FDA rushes to authorize treatments for dogs and cats, a critical step in national preparedness.

The Hume Band challenges rivals with a no-subscription model and longevity tracking, but user complaints and questions about its tech cloud its bold promises.

INRS professor Roberto Morandotti is the first in Canada to win the prestigious optics prize, recognizing breakthroughs that pave the way for quantum technologies.

INmune Bio will present key Phase III results for CORDStrom, a systemic cell therapy for the devastating rare skin disease RDEB. Will it be a breakthrough?

A new report reveals Americans face a $5 trillion annual bill burden, with essential costs consuming an alarming share of income and pushing families to the brink.

Verana Health's new AI-driven datasets offer an unprecedented end-to-end view of the patient journey, aiming to accelerate urologic cancer research.

Utah's BZI appoints a long-term veteran as President and rebrands key divisions, cementing its strategy for national growth through talent and innovation.

LifeStation's new reporting service gives care managers instant data after a medical alert, aiming to cut costs and transform Medicaid care coordination.

Fox Corporation will double the government's $1,000 'Trump Account' deposit for employees' children, a move lauded as a benefit but also raising questions.

Dwight Capital and its affiliate REIT closed over $350M in deals, leveraging HUD loans and bridge financing to support major housing projects in Miami and Newark.